Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A comprehensive review on the antiviral activities of chalcones76
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects62
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease44
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances39
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status38
Targetting ferroptosis for blood cell-related diseases38
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics36
ABC transporters in breast cancer: their roles in multidrug resistance and beyond35
Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications33
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway32
The relevant targets of anti-oxidative stress: a review31
A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application31
Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats29
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide29
Niosomal formulation for antibacterial applications28
An updated review on exosomes: biosynthesis to clinical applications27
Mitochondria autophagy: a potential target for cancer therapy27
Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis26
Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation26
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease25
Potential inhibitors of SARS-CoV-2: recent advances25
Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells21
Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway21
PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery21
MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson’s disease21
0.13141703605652